Low and high voltage electroporation of in vitro human ovarian adenocarcinoma cells

Raji Sundararajan, Arutselvan Natarajan, Kavitha Sankaranarayanan, Lisa M. Reece, Brent Vernon

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

The pitiful, overall cure rate of only approximately 30% of ovarian cancer for several years now indicates the complexity of the organ and the inadequacy of current standard of care. Often the tumors are also chemo-resistant. Thus, there is a critical need for alternate therapies. Electroporation, a physical technique of applying high intensity electrical voltage pulses of appropriate magnitude for short durations (microseconds) that transiently creates pores or permeabilizes cell membranes, enabling macromolecules to pass through which otherwise are impermeable, is a viable alternative. This technique, which has a wide scope in in vitro biotechnology to deliver molecules inside any living cell, is also currently being exploited for therapeutic purposes. Here we report our results on the application of various low and high voltage pulses of different durations and their effect on the viability of SKOV-3, human ovarian cancer cells. This treatment modality, using electrical pulses only paves the way for adapting this technique for alternate clinical treatment of ovarian cancer patients.

Original languageEnglish (US)
Title of host publicationElectroporation-Based Therapies for Cancer
Subtitle of host publicationFrom Basics to Clinical Applications
PublisherElsevier
Pages199-218
Number of pages20
ISBN (Electronic)9781907568152
ISBN (Print)9781908818294
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Keywords

  • adenocarcinoma
  • electroporation
  • fluorescence microscopy
  • light microscopy
  • live/dead assay
  • ovarian cancer
  • SKOV–3 cells
  • voltage pulses

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Low and high voltage electroporation of in vitro human ovarian adenocarcinoma cells'. Together they form a unique fingerprint.

Cite this